Discovery & Development

What progress is being made in the development of novel drugs in neuroscience?

Is pharma now ushering in a new era of precision in neuroscience R&D?

Traversing the blood-brain-barrier using nanoparticle technology.

Parkinson’s UK is accelerating drug development through its virtual biotech.

CRISPR and bioengineering are hot topics from our Cell + Gene Curator roundup.

When it comes to clinical trials, is pharma making the best use of digital technologies?

What happens when the same batch of powder gives different results when tested with different laser diffraction testing machines?

A diabetes drug repurposed for treating obesity shows promise.

We have vaccines. Now, pharma’s mission is to address novel variants. And vaccine hesitancy.

Ensuring that options for patients living with rare diseases aren’t scarce.